195 related articles for article (PubMed ID: 11289059)
21. Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.
Blancou P; Mallone R; Martinuzzi E; Sévère S; Pogu S; Novelli G; Bruno G; Charbonnel B; Dolz M; Chaillous L; van Endert P; Bach JM
J Immunol; 2007 Jun; 178(11):7458-66. PubMed ID: 17513797
[TBL] [Abstract][Full Text] [Related]
22. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera.
Notkins AL; Zhang B; Matsumoto Y; Lan MS
J Autoimmun; 1997 Jun; 10(3):245-50. PubMed ID: 9218750
[TBL] [Abstract][Full Text] [Related]
23. Alternative splicing and differential expression of the islet autoantigen IGRP between pancreas and thymus contributes to immunogenicity of pancreatic islets but not diabetogenicity in humans.
de Jong VM; Abreu JR; Verrijn Stuart AA; van der Slik AR; Verhaeghen K; Engelse MA; Blom B; Staal FJ; Gorus FK; Roep BO
Diabetologia; 2013 Dec; 56(12):2651-8. PubMed ID: 24030068
[TBL] [Abstract][Full Text] [Related]
24. IDA-1, a Caenorhabditis elegans homolog of the diabetic autoantigens IA-2 and phogrin, is expressed in peptidergic neurons in the worm.
Zahn TR; Macmorris MA; Dong W; Day R; Hutton JC
J Comp Neurol; 2001 Jan; 429(1):127-43. PubMed ID: 11086294
[TBL] [Abstract][Full Text] [Related]
25. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
26. Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes.
Farilla L; Tiberti C; Luzzago A; Yu L; Eisenbarth GS; Cortese R; Dotta F; Di Mario U
Eur J Immunol; 2002 May; 32(5):1420-7. PubMed ID: 11981830
[TBL] [Abstract][Full Text] [Related]
27. Engineering and expression of the intracellular domain of insulinoma-associated tyrosine phosphatase (IA-2ic), a type 1 diabetes autoantigen, in plants.
Mett V; Shamloul AM; Hirai H; Zhou Z; Notkins A; Yusibov V
Transgenic Res; 2007 Feb; 16(1):77-84. PubMed ID: 17103024
[TBL] [Abstract][Full Text] [Related]
28. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.
Harfouch-Hammoud E; Walk T; Otto H; Jung G; Bach JF; van Endert PM; Caillat-Zucman S
Diabetes; 1999 Oct; 48(10):1937-47. PubMed ID: 10512357
[TBL] [Abstract][Full Text] [Related]
29. Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice.
Kubosaki A; Gross S; Miura J; Saeki K; Zhu M; Nakamura S; Hendriks W; Notkins AL
Diabetes; 2004 Jul; 53(7):1684-91. PubMed ID: 15220191
[TBL] [Abstract][Full Text] [Related]
30. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.
Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG
Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150
[TBL] [Abstract][Full Text] [Related]
31. Effect of proinflammatory cytokines on gene expression of the diabetes-associated autoantigen IA-2 in INS-1 cells.
Steinbrenner H; Nguyen TB; Wohlrab U; Scherbaum WA; Seissler J
Endocrinology; 2002 Oct; 143(10):3839-45. PubMed ID: 12239095
[TBL] [Abstract][Full Text] [Related]
32. Expression of the protein tyrosine phosphatase-like protein IA-2 during pancreatic islet development.
Roberts C; Roberts GA; Löbner K; Bearzatto M; Clark A; Bonifacio E; Christie MR
J Histochem Cytochem; 2001 Jun; 49(6):767-76. PubMed ID: 11373323
[TBL] [Abstract][Full Text] [Related]
33. IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes.
Tiberti C; Verrienti A; Fiore B; Yu L; Eisenbarth GS; Dotta F; Di Mario U
Clin Immunol; 2005 Jun; 115(3):260-7. PubMed ID: 15893693
[TBL] [Abstract][Full Text] [Related]
34. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2.
Hawkes CJ; Wasmeier C; Christie MR; Hutton JC
Diabetes; 1996 Sep; 45(9):1187-92. PubMed ID: 8772720
[TBL] [Abstract][Full Text] [Related]
35. Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes.
Kawasaki E; Yu L; Rewers MJ; Hutton JC; Eisenbarth GS
Diabetes; 1998 May; 47(5):733-42. PubMed ID: 9588444
[TBL] [Abstract][Full Text] [Related]
36. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.
Hawa M; Rowe R; Lan MS; Notkins AL; Pozzilli P; Christie MR; Leslie RD
Diabetes; 1997 Aug; 46(8):1270-5. PubMed ID: 9231650
[TBL] [Abstract][Full Text] [Related]
37. Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes.
Kawasaki E; Hutton JC; Eisenbarth GS
Biochem Biophys Res Commun; 1996 Oct; 227(2):440-7. PubMed ID: 8878534
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells.
Seissler J; Nguyen TB; Aust G; Steinbrenner H; Scherbaum WA
Diabetes; 2000 Jul; 49(7):1137-41. PubMed ID: 10909970
[TBL] [Abstract][Full Text] [Related]
39. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.
Passini N; Larigan JD; Genovese S; Appella E; Sinigaglia F; Rogge L
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9412-6. PubMed ID: 7568143
[TBL] [Abstract][Full Text] [Related]
40. An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: human and macaque sequences, tissue distribution, unique and shared epitopes, and predictive autoantibodies.
LaGasse J; Jelinek L; Sexson S; Lofton-Day C; Breininger J; Sheppard P; Kindsvogel W; Hagopian WA
Mol Med; 1997 Mar; 3(3):163-73. PubMed ID: 9100223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
